Market Overview

Benzinga's Top Upgrades, Downgrades For July 23, 2019

Share:

Upgrades

  • For Columbia Sportswear Co (NASDAQ: COLM), Bank of America upgraded the previous rating of Neutral to the current rating Buy. Columbia Sportswear earned $1.07 in the first quarter, compared to $0.77 in the year-ago quarter. Columbia Sportswear's market cap stands at $6,978,337,486. At the moment, the stock has a 52-week-high of $109.74 and a 52-week-low of $80.03. Columbia Sportswear closed at $102.17 at the end of the last trading period.
  • For Infinera Corp (NASDAQ: INFN), B. Riley upgraded the previous rating of Neutral to the current rating Buy. Infinera earned ($0.23) in the first quarter, compared to ($0.05) in the year-ago quarter. Infinera's market cap stands at $599,121,646. At the moment, the stock has a 52-week-high of $9.94 and a 52-week-low of $2.80. Infinera closed at $3.37 at the end of the last trading period.
  • For Karyopharm Therapeutics Inc (NASDAQ: KPTI), JP Morgan upgraded the previous rating of Neutral to the current rating Overweight. Karyopharm Therapeutics earned ($1.09) in the first quarter, compared to ($0.78) in the year-ago quarter. Karyopharm Therapeutics's market cap stands at $507,000,826. At the moment, the stock has a 52-week-high of $21.71 and a 52-week-low of $3.92. Karyopharm Therapeutics closed at $8.33 at the end of the last trading period.
  • For Murphy Oil Corp (NYSE: MUR), Goldman Sachs upgraded the previous rating of Neutral to the current rating Buy. Murphy Oil earned $0.15 in the first quarter, compared to $0.23 in the year-ago quarter. Murphy Oil's market cap stands at $3,837,156,655. At the moment, the stock has a 52-week-high of $36.53 and a 52-week-low of $21.20. Murphy Oil closed at $22.10 at the end of the last trading period.
  • For Semgroup Corp (NYSE: SEMG), Citi upgraded the previous rating of Neutral to the current rating Buy. Semgroup earned ($0.37) in the first quarter, compared to ($0.48) in the year-ago quarter. Semgroup's market cap stands at $948,182,491. At the moment, the stock has a 52-week-high of $26.79 and a 52-week-low of $11.06. Semgroup closed at $11.91 at the end of the last trading period.
  • For Snap Inc (NYSE: SNAP), Stifel Nicolaus upgraded the previous rating of Hold to the current rating Buy. Snap earned No EPS Value in the second quarter, compared to ($0.14) in the year-ago quarter. Snap's market cap stands at $19,162,459,464. At the moment, the stock has a 52-week-high of $16.24 and a 52-week-low of $4.82. Snap closed at $14.16 at the end of the last trading period.

 

Downgrades

  • For Baidu Inc (NASDAQ: BIDU), OTR Global downgraded the previous rating of Positive to the current rating Mixed. Baidu earned $0.41 in the first quarter, compared to $2.60 in the year-ago quarter. Baidu's market cap stands at $39,096,710,127. At the moment, the stock has a 52-week-high of $265.73 and a 52-week-low of $106.80. Baidu closed at $111.70 at the end of the last trading period.
  • For Cadence Bancorp (NYSE: CADE), Goldman Sachs downgraded the previous rating of Buy to the current rating Neutral. Cadence Bancorp earned $0.40 in the second quarter, compared to $0.57 in the year-ago quarter. Cadence Bancorp's market cap stands at $2,042,699,199. At the moment, the stock has a 52-week-high of $29.70 and a 52-week-low of $15.55. Cadence Bancorp closed at $15.86 at the end of the last trading period.
  • For Cadence Bancorp (NYSE: CADE), Keefe Bruyette & Woods downgraded the previous rating of Outperform to the current rating Market Perform. Cadence Bancorp earned $0.40 in the second quarter, compared to $0.57 in the year-ago quarter. Cadence Bancorp's market cap stands at $2,042,699,199. At the moment, the stock has a 52-week-high of $29.70 and a 52-week-low of $15.55. Cadence Bancorp closed at $15.86 at the end of the last trading period.
  • For Condor Hospitality Trust Inc (AMEX: CDOR), B. Riley downgraded the previous rating of Buy to the current rating Neutral. Condor Hospitality Trust earned ($0.01) in the first quarter, compared to $0.05 in the year-ago quarter. Condor Hospitality Trust's market cap stands at $130,770,901. At the moment, the stock has a 52-week-high of $11.32 and a 52-week-low of $6.10. Condor Hospitality Trust closed at $10.96 at the end of the last trading period.
  • For Condor Hospitality Trust Inc (AMEX: CDOR), Janney Capital downgraded the previous rating of Buy to the current rating Neutral. Condor Hospitality Trust earned ($0.01) in the first quarter, compared to $0.05 in the year-ago quarter. Condor Hospitality Trust's market cap stands at $130,770,901. At the moment, the stock has a 52-week-high of $11.32 and a 52-week-low of $6.10. Condor Hospitality Trust closed at $10.96 at the end of the last trading period.
  • For Cognizant Technology Solutions Corp (NASDAQ: CTSH), HSBC downgraded the previous rating of Buy to the current rating Hold. Cognizant Tech Solns earned $0.91 in the first quarter, compared to $1.06 in the year-ago quarter. Cognizant Tech Solns's market cap stands at $37,316,496,717. At the moment, the stock has a 52-week-high of $83.30 and a 52-week-low of $56.73. Cognizant Tech Solns closed at $65.55 at the end of the last trading period.
  • For Digital Realty Trust Inc (NYSE: DLR), Cowen & Co. downgraded the previous rating of Outperform to the current rating Market Perform. Digital Realty Trust earned $1.73 in the first quarter. Digital Realty Trust's market cap stands at $24,487,824,080. At the moment, the stock has a 52-week-high of $125.19 and a 52-week-low of $100.05. Digital Realty Trust closed at $117.56 at the end of the last trading period.
  • For Eldorado Gold Corp (NYSE: EGO), National Bank Financial downgraded the previous rating of Outperform to the current rating Sector Perform. Eldorado Gold earned ($0.11) in the first quarter, compared to $0.01 in the year-ago quarter. Eldorado Gold's market cap stands at $1,243,115,566. At the moment, the stock has a 52-week-high of $7.96 and a 52-week-low of $2.52. Eldorado Gold closed at $7.80 at the end of the last trading period.
  • For Eldorado Gold Corp (NYSE: EGO), GMP Securities downgraded the previous rating of Buy to the current rating Hold. Eldorado Gold earned ($0.11) in the first quarter, compared to $0.01 in the year-ago quarter. Eldorado Gold's market cap stands at $1,243,115,566. At the moment, the stock has a 52-week-high of $7.96 and a 52-week-low of $2.52. Eldorado Gold closed at $7.80 at the end of the last trading period.
  • For Franco-Nevada Corp (NYSE: FNV), GMP Securities downgraded the previous rating of Buy to the current rating Hold. Franco-Nevada earned $0.35 in the first quarter, compared to $0.34 in the year-ago quarter. Franco-Nevada's market cap stands at $16,976,494,597. At the moment, the stock has a 52-week-high of $90.76 and a 52-week-low of $58.26. Franco-Nevada closed at $90.32 at the end of the last trading period.
  • For Iamgold Corp (NYSE: IAG), GMP Securities downgraded the previous rating of Buy to the current rating Hold. Iamgold earned $0.00 in the first quarter, compared to $0.09 in the year-ago quarter. Iamgold's market cap stands at $1,773,997,863. At the moment, the stock has a 52-week-high of $5.86 and a 52-week-low of $2.28. Iamgold closed at $3.76 at the end of the last trading period.
  • For Sprouts Farmers Market Inc (NASDAQ: SFM), Oppenheimer downgraded the previous rating of Outperform to the current rating Perform. Sprouts Farmers Market earned $0.46 in the first quarter, compared to $0.50 in the year-ago quarter. Sprouts Farmers Market's market cap stands at $2,039,459,084. At the moment, the stock has a 52-week-high of $29.67 and a 52-week-low of $17.26. Sprouts Farmers Market closed at $17.29 at the end of the last trading period.
  • For Peak Resorts Inc (NASDAQ: SKIS), Stifel Nicolaus downgraded the previous rating of Buy to the current rating Hold. Peak Resorts earned $0.83 in the fourth quarter, compared to $0.56 in the year-ago quarter. Peak Resorts's market cap stands at $164,549,277. At the moment, the stock has a 52-week-high of $10.89 and a 52-week-low of $3.75. Peak Resorts closed at $10.85 at the end of the last trading period.
  • For Viveve Medical Inc (NASDAQ: VIVE), Raymond James downgraded the previous rating of Outperform to the current rating Market Perform. Viveve Medical earned ($0.22) in the first quarter, compared to ($0.49) in the year-ago quarter. Viveve Medical's market cap stands at $18,962,867. At the moment, the stock has a 52-week-high of $3.71 and a 52-week-low of $0.35. Viveve Medical closed at $0.41 at the end of the last trading period.
  • For Viveve Medical Inc (NASDAQ: VIVE), Stifel Nicolaus downgraded the previous rating of Buy to the current rating Hold. Viveve Medical earned ($0.22) in the first quarter, compared to ($0.49) in the year-ago quarter. Viveve Medical's market cap stands at $18,962,867. At the moment, the stock has a 52-week-high of $3.71 and a 52-week-low of $0.35. Viveve Medical closed at $0.41 at the end of the last trading period.
  • For Viveve Medical Inc (NASDAQ: VIVE), Mizuho Securities downgraded the previous rating of Buy to the current rating Underperform. Viveve Medical earned ($0.22) in the first quarter, compared to ($0.49) in the year-ago quarter. Viveve Medical's market cap stands at $18,962,867. At the moment, the stock has a 52-week-high of $3.71 and a 52-week-low of $0.35. Viveve Medical closed at $0.41 at the end of the last trading period.
  • For Viveve Medical Inc (NASDAQ: VIVE), Mizuho downgraded the previous rating of Buy to the current rating Underperform. Viveve Medical earned ($0.22) in the first quarter, compared to ($0.49) in the year-ago quarter. Viveve Medical's market cap stands at $18,962,867. At the moment, the stock has a 52-week-high of $3.71 and a 52-week-low of $0.35. Viveve Medical closed at $0.41 at the end of the last trading period.
  • For Viveve Medical Inc (NASDAQ: VIVE), Maxim Group downgraded the previous rating of Buy to the current rating Hold. Viveve Medical earned ($0.22) in the first quarter, compared to ($0.49) in the year-ago quarter. Viveve Medical's market cap stands at $18,962,867. At the moment, the stock has a 52-week-high of $3.71 and a 52-week-low of $0.35. Viveve Medical closed at $0.41 at the end of the last trading period.
  • For Zions Bancorp NA (NASDAQ: ZION), Wells Fargo downgraded the previous rating of Outperform to the current rating Market Perform. Zions Bancorp earned $0.99 in the second quarter, compared to $0.89 in the year-ago quarter. Zions Bancorp's market cap stands at $8,257,429,830. At the moment, the stock has a 52-week-high of $54.76 and a 52-week-low of $38.08. Zions Bancorp closed at $45.23 at the end of the last trading period.
  • For Zions Bancorp NA (NASDAQ: ZION), Keefe Bruyette & Woods downgraded the previous rating of Outperform to the current rating Market Perform. Zions Bancorp earned $0.99 in the second quarter, compared to $0.89 in the year-ago quarter. Zions Bancorp's market cap stands at $8,257,429,830. At the moment, the stock has a 52-week-high of $54.76 and a 52-week-low of $38.08. Zions Bancorp closed at $45.23 at the end of the last trading period.

 

Initiations

  • BTIG Research initiated coverage on Adaptive Biotechnologies Corp (NASDAQ: ADPT) with a Buy rating. The price target for Adaptive Biotechnologies is set to $46.00. Adaptive Biotechnologies earned $0.06 in the third quarter, compared to $0.31 in the year-ago quarter. Adaptive Biotechnologies's market cap stands at $4,839,015,512. At the moment, the stock has a 52-week-high of $51.00 and a 52-week-low of $36.21. Adaptive Biotechnologies closed at $39.27 at the end of the last trading period.
  • RBC Capital initiated coverage on Broadcom Inc (NASDAQ: AVGO) with an Outperform rating. The price target for Broadcom is set to $320.00. Broadcom earned $5.21 in the second quarter, compared to $4.88 in the year-ago quarter. Broadcom's market cap stands at $117,889,489,532. At the moment, the stock has a 52-week-high of $323.20 and a 52-week-low of $202.77. Broadcom closed at $296.15 at the end of the last trading period.
  • Loop Capital initiated coverage on Bloomin Brands Inc (NASDAQ: BLMN) with a Buy rating. The price target for Bloomin Brands is set to $22.00. Bloomin Brands earned $0.75 in the first quarter, compared to $0.71 in the year-ago quarter. Bloomin Brands's market cap stands at $1,603,015,985. At the moment, the stock has a 52-week-high of $22.22 and a 52-week-low of $17.00. Bloomin Brands closed at $17.48 at the end of the last trading period.
  • Keefe Bruyette & Woods initiated coverage on Cambridge Bancorp (NASDAQ: CATC) with a Market Perform rating. The price target for Cambridge is set to $90.00. Cambridge earned $1.47 in the second quarter, compared to $1.48 in the year-ago quarter. Cambridge's market cap stands at $389,473,469. At the moment, the stock has a 52-week-high of $95.06 and a 52-week-low of $71.34. Cambridge closed at $80.30 at the end of the last trading period.
  • Buckingham Research initiated coverage on Cowen Inc (NASDAQ: COWN) with a Buy rating. The price target for Cowen is set to $20.00. Cowen earned $0.48 in the first quarter, compared to $0.79 in the year-ago quarter. Cowen's market cap stands at $469,831,126. At the moment, the stock has a 52-week-high of $17.99 and a 52-week-low of $11.80. Cowen closed at $15.88 at the end of the last trading period.
  • Buckingham initiated coverage on Cowen Inc (NASDAQ: COWN) with a Buy rating. Cowen earned $0.48 in the first quarter, compared to $0.79 in the year-ago quarter. Cowen's market cap stands at $469,831,126. At the moment, the stock has a 52-week-high of $17.99 and a 52-week-low of $11.80. Cowen closed at $15.88 at the end of the last trading period.
  • KeyBanc initiated coverage on Darden Restaurants Inc (NYSE: DRI) with an Overweight rating. The price target for Darden Restaurants is set to $140.00. Darden Restaurants earned $1.76 in the fourth quarter, compared to $1.39 in the year-ago quarter. Darden Restaurants's market cap stands at $15,441,675,891. At the moment, the stock has a 52-week-high of $125.99 and a 52-week-low of $95.83. Darden Restaurants closed at $125.47 at the end of the last trading period.
  • KeyBanc initiated coverage on Brinker International Inc (NYSE: EAT) with a Sector Weight rating. Brinker International earned $1.26 in the third quarter, compared to $1.08 in the year-ago quarter. Brinker International's market cap stands at $1,521,375,000. At the moment, the stock has a 52-week-high of $53.61 and a 52-week-low of $36.82. Brinker International closed at $40.56 at the end of the last trading period.
  • Benchmark initiated coverage on Intel Corp (NASDAQ: INTC) with a Hold rating. Intel earned $0.89 in the first quarter, compared to $0.87 in the year-ago quarter. Intel's market cap stands at $229,893,950,000. At the moment, the stock has a 52-week-high of $59.59 and a 52-week-low of $42.36. Intel closed at $51.35 at the end of the last trading period.
  • Citi initiated coverage on Karuna Therapeutics Inc (NASDAQ: KRTX) with a Buy rating. The price target for Karuna Therapeutics is set to $28.00. Karuna Therapeutics's market cap stands at $462,167,763. At the moment, the stock has a 52-week-high of $29.00 and a 52-week-low of $17.26. Karuna Therapeutics closed at $19.74 at the end of the last trading period.
  • Wells Fargo initiated coverage on Karuna Therapeutics Inc (NASDAQ: KRTX) with an Outperform rating. Karuna Therapeutics's market cap stands at $462,167,763. At the moment, the stock has a 52-week-high of $29.00 and a 52-week-low of $17.26. Karuna Therapeutics closed at $19.74 at the end of the last trading period.
  • Goldman Sachs initiated coverage on Karuna Therapeutics Inc (NASDAQ: KRTX) with a Buy rating. The price target for Karuna Therapeutics is set to $34.00. Karuna Therapeutics's market cap stands at $462,167,763. At the moment, the stock has a 52-week-high of $29.00 and a 52-week-low of $17.26. Karuna Therapeutics closed at $19.74 at the end of the last trading period.
  • Wedbush initiated coverage on Karuna Therapeutics Inc (NASDAQ: KRTX) with an Outperform rating. The price target for Karuna Therapeutics is set to $38.00. Karuna Therapeutics's market cap stands at $462,167,763. At the moment, the stock has a 52-week-high of $29.00 and a 52-week-low of $17.26. Karuna Therapeutics closed at $19.74 at the end of the last trading period.
  • Chardan Capital initiated coverage on Phreesia Inc (NYSE: PHR) with a Buy rating. The price target for Phreesia is set to $33.00. Phreesia's market cap stands at $851,453,663. At the moment, the stock has a 52-week-high of $27.59 and a 52-week-low of $23.00. Phreesia closed at $23.90 at the end of the last trading period.
  • KeyBanc initiated coverage on The RealReal Inc (NASDAQ: REAL) with an Overweight rating. The price target for The RealReal is set to $31.00. The RealReal earned ($0.08) in the second quarter. The RealReal's market cap stands at $2,050,149,634. At the moment, the stock has a 52-week-high of $30.05 and a 52-week-low of $22.91. The RealReal closed at $24.79 at the end of the last trading period.
  • UBS initiated coverage on The RealReal Inc (NASDAQ: REAL) with a Buy rating. The price target for The RealReal is set to $30.00. The RealReal earned ($0.08) in the second quarter. The RealReal's market cap stands at $2,050,149,634. At the moment, the stock has a 52-week-high of $30.05 and a 52-week-low of $22.91. The RealReal closed at $24.79 at the end of the last trading period.
  • Stifel initiated coverage on The RealReal Inc (NASDAQ: REAL) with a Buy rating. The price target for The RealReal is set to $30.00. The RealReal earned ($0.08) in the second quarter. The RealReal's market cap stands at $2,050,149,634. At the moment, the stock has a 52-week-high of $30.05 and a 52-week-low of $22.91. The RealReal closed at $24.79 at the end of the last trading period.
  • Raymond James initiated coverage on The RealReal Inc (NASDAQ: REAL) with a Market Perform rating. The RealReal earned ($0.08) in the second quarter. The RealReal's market cap stands at $2,050,149,634. At the moment, the stock has a 52-week-high of $30.05 and a 52-week-low of $22.91. The RealReal closed at $24.79 at the end of the last trading period.
  • Cowen & Co. initiated coverage on The RealReal Inc (NASDAQ: REAL) with an Outperform rating. The price target for The RealReal is set to $32.00. The RealReal earned ($0.08) in the second quarter. The RealReal's market cap stands at $2,050,149,634. At the moment, the stock has a 52-week-high of $30.05 and a 52-week-low of $22.91. The RealReal closed at $24.79 at the end of the last trading period.
  • Bank of America initiated coverage on The RealReal Inc (NASDAQ: REAL) with a Neutral rating. The price target for The RealReal is set to $28.00. The RealReal earned ($0.08) in the second quarter. The RealReal's market cap stands at $2,050,149,634. At the moment, the stock has a 52-week-high of $30.05 and a 52-week-low of $22.91. The RealReal closed at $24.79 at the end of the last trading period.
  • Chardan Capital initiated coverage on Replimune Group Inc (NASDAQ: REPL) with a Buy rating. The price target for Replimune Group is set to $28.00. Replimune Group earned ($0.15) in the fourth quarter. Replimune Group's market cap stands at $390,730,070. At the moment, the stock has a 52-week-high of $23.55 and a 52-week-low of $8.88. Replimune Group closed at $12.34 at the end of the last trading period.
  • Benchmark initiated coverage on Silicon Laboratories Inc (NASDAQ: SLAB) with a Buy rating. The price target for Silicon Laboratories is set to $120.00. Silicon Laboratories earned $0.59 in the first quarter, compared to $0.87 in the year-ago quarter. Silicon Laboratories's market cap stands at $4,560,295,932. At the moment, the stock has a 52-week-high of $110.43 and a 52-week-low of $73.13. Silicon Laboratories closed at $105.22 at the end of the last trading period.
  • Rosenblatt initiated coverage on Snap Inc (NYSE: SNAP) with a Buy rating. The price target for Snap is set to $18.00. Snap earned No EPS Value in the second quarter, compared to ($0.14) in the year-ago quarter. Snap's market cap stands at $19,162,459,464. At the moment, the stock has a 52-week-high of $16.24 and a 52-week-low of $4.82. Snap closed at $14.16 at the end of the last trading period.
  • Rosenblatt initiated coverage on Twitter Inc (NYSE: TWTR) with a Neutral rating. The price target for Twitter is set to $38.00. Twitter earned $0.37 in the first quarter, compared to $0.16 in the year-ago quarter. Twitter's market cap stands at $28,885,164,404. At the moment, the stock has a 52-week-high of $44.39 and a 52-week-low of $26.19. Twitter closed at $37.53 at the end of the last trading period.
  • KeyBanc initiated coverage on Texas Roadhouse Inc (NASDAQ: TXRH) with a Sector Weight rating. Texas Roadhouse earned $0.70 in the first quarter, compared to $0.76 in the year-ago quarter. Texas Roadhouse's market cap stands at $3,912,685,063. At the moment, the stock has a 52-week-high of $75.24 and a 52-week-low of $50.84. Texas Roadhouse closed at $54.47 at the end of the last trading period.
  • Benchmark initiated coverage on Xilinx Inc (NASDAQ: XLNX) with a Hold rating. Xilinx earned $0.94 in the fourth quarter, compared to $0.76 in the year-ago quarter. Xilinx's market cap stands at $31,183,271,942. At the moment, the stock has a 52-week-high of $141.60 and a 52-week-low of $66.35. Xilinx closed at $124.23 at the end of the last trading period.

Posted-In: Initiations top upgradesUpgrades Downgrades Initiation Intraday Update Analyst Ratings

 

Related Articles (AVGO + ADPT)

View Comments and Join the Discussion!

Latest Ratings

StockFirmActionPT
WUBABOCOM InternationalDowngrades
DLTROTR GlobalUpgrades
ARCCCompass PointDowngrades
GTYHCitiInitiates Coverage On7.0
NKEGuggenheimMaintains100.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com

Marinus Sinks To 2-Year Low As Postpartum Depression Drug Found Ineffective At 28 Days

Harris, Nadler Introduce Comprehensive Federal Cannabis Reform Bill